These findings not only support the potential use of Gal-3 as a biomarker for BD disease but also strongly suggest its potential as a phase marker for the euthymic period, which is the most difficult and complex period to diagnose, especially at the initial presentation. Here, LGALS3 is linked to Behcet disease.